Nonoperating Income (Expense) in USD of Protara Therapeutics, Inc. from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Protara Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to Q3 2025.
  • Protara Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $1.5M, a 35.2% increase year-over-year.
  • Protara Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $6.88M, a 79.4% increase year-over-year.
  • Protara Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $4.56M, a 42.8% increase from 2023.
  • Protara Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $3.19M, a 188% increase from 2022.
  • Protara Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.11M, a 368% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

Protara Therapeutics, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $6.88M $1.5M +$391K +35.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $6.49M $1.63M +$478K +41.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $6.01M $2.21M +$1.45M +192% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $4.56M $1.54M +$723K +88.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-05
Q3 2024 $3.84M $1.11M +$271K +32.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $3.56M $1.15M +$302K +35.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 $3.26M $756K +$69K +10% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $3.19M $820K +$278K +51.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-05
Q3 2023 $2.92M $840K +$557K +197% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $2.36M $846K +$680K +410% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $1.68M $687K +$568K +477% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $1.11M $542K +$483K +819% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $627K $283K +$230K +434% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $397K $166K +$156K +1560% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $241K $119K +$4K +3.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $237K $59K -$89K -60.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $326K $53K -$39K -42.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $365K $10K -$116K -92.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $481K $115K +$15K +15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $466K $148K +$118K +393% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 $348K $92K +$37K +67.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $311K $126K +$55K +77.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $256K $100K -$6K -5.66% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $262K $30K -$96K -76.2% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-20
Q3 2019 $358K $55K -$57K -50.9% Jul 1, 2019 Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $415K $71K -$50K -41.3% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $465K $106K -$178K -62.7% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $643K $126K +$87K +223% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 $556K $112K +$113K Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $443K $121K -$257K -68% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $700K $284K +$302K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $398K $39K +$135K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 $263K -$1K -$60K -102% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $323K $378K +$429K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$106K -$18K -$285K -107% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $179K -$96K +$59K +38.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-13
Q3 2016 $120K $59K +$360K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$240K -$51K +$40K +44% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$280K $267K +$227K +568% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$507K -$155K -$10.7M -101% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $10.2M -$301K +$5.01M +94.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $5.14M -$91K -$36K -65.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $5.18M $40K +$938K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $4.24M $10.5M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$5.32M -$5.3M -29428% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$55K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$898K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 -$18K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-25

Protara Therapeutics, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.56M +$1.37M +42.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 $3.19M +$2.08M +188% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 $1.11M +$873K +368% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $237K -$229K -49.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $466K +$204K +77.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $262K -$381K -59.3% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-20
2018 $643K +$245K +61.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $398K +$219K +122% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $179K +$686K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 -$507K -$4.75M -112% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $4.24M +$5.03M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$790K -$816K -3138% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $26K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.